LU71223A1 - - Google Patents

Info

Publication number
LU71223A1
LU71223A1 LU71223A LU71223A LU71223A1 LU 71223 A1 LU71223 A1 LU 71223A1 LU 71223 A LU71223 A LU 71223A LU 71223 A LU71223 A LU 71223A LU 71223 A1 LU71223 A1 LU 71223A1
Authority
LU
Luxembourg
Application number
LU71223A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU71223A1 publication Critical patent/LU71223A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
LU71223A 1973-11-03 1974-10-31 LU71223A1 (cg-RX-API-DMAC10.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2355094A DE2355094C3 (de) 1973-11-03 1973-11-03 Verfahren zur Herstellung eines Tetanus-Impfstoffs

Publications (1)

Publication Number Publication Date
LU71223A1 true LU71223A1 (cg-RX-API-DMAC10.html) 1976-08-19

Family

ID=5897187

Family Applications (1)

Application Number Title Priority Date Filing Date
LU71223A LU71223A1 (cg-RX-API-DMAC10.html) 1973-11-03 1974-10-31

Country Status (15)

Country Link
US (1) US4007265A (cg-RX-API-DMAC10.html)
JP (1) JPS5071820A (cg-RX-API-DMAC10.html)
AT (1) AT336784B (cg-RX-API-DMAC10.html)
AU (1) AU497398B2 (cg-RX-API-DMAC10.html)
BE (1) BE821833A (cg-RX-API-DMAC10.html)
CA (1) CA1038293A (cg-RX-API-DMAC10.html)
DE (1) DE2355094C3 (cg-RX-API-DMAC10.html)
DK (1) DK143383C (cg-RX-API-DMAC10.html)
FR (1) FR2249679B1 (cg-RX-API-DMAC10.html)
GB (1) GB1492596A (cg-RX-API-DMAC10.html)
IE (1) IE40098B1 (cg-RX-API-DMAC10.html)
IL (1) IL45960A (cg-RX-API-DMAC10.html)
IT (1) IT1043904B (cg-RX-API-DMAC10.html)
LU (1) LU71223A1 (cg-RX-API-DMAC10.html)
NL (1) NL7414114A (cg-RX-API-DMAC10.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2510987C2 (de) 1974-10-29 1983-03-24 Behringwerke Ag, 3550 Marburg Verfahren zur Herstellung eines Tetanusimpfstoffes
DE2457047C3 (de) * 1974-12-03 1979-10-31 Behringwerke Ag, 3550 Marburg Verfahren zur Herstellung eines Derivates der leichten Kette des Tetanustoxins, dessen Verwendung zur Tetanusprophylaxe
US4200627A (en) 1976-07-31 1980-04-29 Behringwerke Aktiengesellschaft Atoxic, immunogenic product of tetanus toxin
US4264588A (en) * 1979-05-10 1981-04-28 The Charles River Breeding Laboratories, Inc. Vaccine for Clostridium perfringens type E enterotoxemia of rabbits
US4330623A (en) * 1980-02-19 1982-05-18 Merck & Co., Inc. Process for solubilization of gonococcal antigen
FR2498192A2 (fr) * 1981-01-22 1982-07-23 Pasteur Institut Nouveau compose polypeptidique thiole provenant d'un fragment de la toxine tetanique, son procede d'obtention et ses applications
HU188847B (en) * 1983-02-22 1986-05-28 Human Oltoanyagtermeloe Es Kutato Intezet,Hu Process for producing liophylized combined vaccines
US5063162A (en) * 1987-04-24 1991-11-05 Hoffmann-La Roche Inc. Process for isolating nucleic acids utilizing protease digestion
DE3817724C2 (de) * 1988-05-25 1996-04-04 Siemens Ag Computertomograph
GB8914122D0 (en) * 1989-06-20 1989-08-09 Wellcome Found Polypeptide expression
US5601826A (en) * 1989-06-30 1997-02-11 The United States Of America As Represented By The Department Of Health And Human Services Peptide which produces protective immunity against tetanus
DE69002817T2 (de) * 1989-11-28 1993-12-09 Wellcome Found Vakzine.
US6372225B1 (en) 1996-03-23 2002-04-16 The Research Foundation Of Microbial Diseases Of Osaka University Tetanus toxin functional fragment antigen and tetanus vaccine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617344B2 (de) * 1967-05-06 1976-04-08 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung eines tetanus-impfstoffes

Also Published As

Publication number Publication date
DE2355094A1 (de) 1975-05-22
US4007265A (en) 1977-02-01
FR2249679B1 (cg-RX-API-DMAC10.html) 1978-07-21
IL45960A (en) 1979-03-12
IE40098B1 (en) 1979-03-14
DK143383B (da) 1981-08-17
DE2355094C3 (de) 1979-05-23
DK571574A (cg-RX-API-DMAC10.html) 1975-06-23
IE40098L (en) 1975-05-03
NL7414114A (nl) 1975-05-07
AU7490974A (en) 1976-05-06
DK143383C (da) 1981-12-21
CA1038293A (en) 1978-09-12
AU497398B2 (en) 1978-12-14
ATA876674A (de) 1976-09-15
GB1492596A (en) 1977-11-23
DE2355094B2 (de) 1978-10-05
FR2249679A1 (cg-RX-API-DMAC10.html) 1975-05-30
JPS5071820A (cg-RX-API-DMAC10.html) 1975-06-14
AT336784B (de) 1977-05-25
BE821833A (fr) 1975-05-05
IT1043904B (it) 1980-02-29

Similar Documents

Publication Publication Date Title
AR201758A1 (cg-RX-API-DMAC10.html)
AU465372B2 (cg-RX-API-DMAC10.html)
AR201235Q (cg-RX-API-DMAC10.html)
AR201231Q (cg-RX-API-DMAC10.html)
AU474593B2 (cg-RX-API-DMAC10.html)
AU465453B2 (cg-RX-API-DMAC10.html)
AU471343B2 (cg-RX-API-DMAC10.html)
AU465434B2 (cg-RX-API-DMAC10.html)
FR2249679B1 (cg-RX-API-DMAC10.html)
AU450229B2 (cg-RX-API-DMAC10.html)
AU476714B2 (cg-RX-API-DMAC10.html)
AR201229Q (cg-RX-API-DMAC10.html)
AR199451A1 (cg-RX-API-DMAC10.html)
AU476696B2 (cg-RX-API-DMAC10.html)
AU472848B2 (cg-RX-API-DMAC10.html)
AU466283B2 (cg-RX-API-DMAC10.html)
AU476873B1 (cg-RX-API-DMAC10.html)
AU477823B2 (cg-RX-API-DMAC10.html)
AR195948A1 (cg-RX-API-DMAC10.html)
AU471461B2 (cg-RX-API-DMAC10.html)
AR200885A1 (cg-RX-API-DMAC10.html)
AR200256A1 (cg-RX-API-DMAC10.html)
AR196382A1 (cg-RX-API-DMAC10.html)
AR193950A1 (cg-RX-API-DMAC10.html)
AR197627A1 (cg-RX-API-DMAC10.html)